Celltrion receives CHMP positive opinion for regdanvimab (CT-P59) as one of the first monoclonal antibodies recommended as a treatment for COVID-19 by the CHMP
• The CHMP optimistic opinion marks the primary time a monoclonal antibody remedy for COVID-19 ...
Read more